Your browser doesn't support javascript.
loading
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
Cheng, Qinglu; Cunningham, Evan B; Shih, Sophy; Amin, Janaki; Bruneau, Julie; Artenie, Adelina A; Powis, Jeff; Litwin, Alain H; Cooper, Curtis; Dalgard, Olav; Hellard, Margaret; Bruggmann, Philip; Marks, Philippa; Lacombe, Karine; Stedman, Catherine; Read, Phillip; Hajarizadeh, Behzad; Dunlop, Adrian J; Conway, Brian; Feld, Jordan J; Dore, Gregory J; Grebely, Jason.
Affiliation
  • Cheng Q; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia. Electronic address: qcheng@kirby.unsw.edu.au.
  • Cunningham EB; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Shih S; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Amin J; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia; Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
  • Bruneau J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada; Département de médecine, Université de Montréal, Montréal, QC, Canada.
  • Artenie AA; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, England, UK.
  • Powis J; Infection Prevention and Control, Michael Garron Hospital, Toronto, ON, Canada.
  • Litwin AH; Prisma Health Addiction Medicine Centre, Greenville, SC, USA; School of Medicine - Greenville, University of South Carolina, Greenville, SC, USA; School of Health Research, Clemson University, Clemson, SC, USA.
  • Cooper C; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hellard M; The Burnet Institute, Melbourne, VIC, Australia; Department of Infectious Disease, The Alfred Hospital, Melbourne, VIC, Australia.
  • Bruggmann P; Arud Centre for Addiction Medicine, Zurich, Switzerland.
  • Marks P; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Lacombe K; Faculté de médecine, Sorbonne Université, Paris, France; Infectious Diseases Department, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Stedman C; Department of Medicine, University of Otago, Christchurch, New Zealand; Gastroenterology Department, Christchurch Hospital, Christchurch, New Zealand.
  • Read P; Kirketon Road Centre, Sydney, NSW, Australia.
  • Hajarizadeh B; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Dunlop AJ; Drug & Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia; Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
  • Conway B; Vancouver Infectious Diseases Centre, Vancouver, BC, Canada.
  • Feld JJ; Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada.
  • Dore GJ; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
  • Grebely J; The Kirby Institute, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
Value Health ; 26(6): 883-892, 2023 06.
Article in En | MEDLINE | ID: mdl-36646278
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Substance Abuse, Intravenous / Hepatitis C / Hepatitis C, Chronic / Drug Users Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Value Health Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Substance Abuse, Intravenous / Hepatitis C / Hepatitis C, Chronic / Drug Users Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Value Health Year: 2023 Document type: Article